Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 210 clinical trials
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well larotrectinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with NTRK fusions that have spread to other places in the body and have come back or do not respond to treatment. Larotrectinib may stop the growth of …

cytotoxic chemotherapy
metastasis
interleukins
cellular therapy
131i-mibg
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 351 views
  • 14 Jan, 2021
  • +81 other locations
GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

The purpose of the study is to evaluate the effect of IONIS-FB-LRx on the rate of change of the area of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) measured by fundus autofluorescence (FAF).

vaccination
age-related macular degeneration
macular degeneration
pneumoniae
fundus autofluorescence imaging
IONIS Investigative Site
 (6.7 away) Contact site
  • 515 views
  • 15 Dec, 2020
  • +141 other locations
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

This phase II Lung-MAP trial studies how well rucaparib works in treating patients with genomic loss of heterozygosity (LOH) high and/or deleterious BRCA1/2 mutation stage IV non-small cell lung cancer or that has come back. Rucaparib may stop the growth of tumor cells by blocking some of the enzymes needed …

cardiac disease
metastasis
skin cancer
stage iv non-small cell lung cancer
parp inhibitor
Northwest Hospital Center
 (3.8 away) Contact site
  • 175 views
  • 17 Nov, 2020
  • +746 other locations
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

This phase II Lung-MAP non-Match treatment trial studies how well ramucirumab and pembrolizumab work versus standard of care in treating patients with non-small cell lung cancer that is stage IV or has come back. Immunotherapy with monoclonal antibodies, such as ramucirumab and pembrolizumab, may help the body's immune system attack …

metastasis
skin cancer
pemetrexed
gemcitabine
hysterectomy
Northwest Hospital Center
 (3.8 away) Contact site
  • 80 views
  • 20 Aug, 2020
  • +628 other locations
Connected Catheter- Safety and Effectiveness Study

The Connected Catheter is a fully internal, urethral indwelling urinary prosthesis designed for improved bladder management in males with urinary retention disorders requiring catheterization. It is a sterile, extended-use device that resides fully internally to the male lower urinary tract for an intended use life of up to 7 days …

New Jersey Urology, 2401 Evesham Road, Suite F
 (100.6 away) Contact site
  • 157 views
  • 08 Jan, 2021
  • +14 other locations
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain

The primary objective of this study is to demonstrate the efficacy and safety of linzagolix administered orally once daily for 3 months at a dose of 75 mg alone or of 200 mg in combination with add-back hormone replacement therapy (ABT: estradiol (E2) 1 mg / norethisterone acetate (NETA) 0.5 …

estradiol
regular menstrual cycles
norethindrone acetate
Continental Clinical Solutions, LLC / ID # 777
 (7.6 away) Contact site
  • 1620 views
  • 07 May, 2020
  • +130 other locations
A Clinical Investigation to Evaluate Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)

Clinical Investigation to demonstrate the effectiveness and safety of Princess Filler Lidocaine in the correction of moderate to severe nasolabial folds

Robert Weiss
 (7.3 away) Contact site
  • 139 views
  • 30 Jun, 2019
  • +10 other locations
Selpercatinib for the Treatment of Advanced Solid Tumors Lymphomas or Histiocytic Disorders With Activating RET Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well selpercatinib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphomas, or histiocytic disorders that have activating RET gene alterations. Selpercatinib may block the growth of cancer cells that have specific genetic changes …

cytotoxic chemotherapy
metastasis
interleukins
cellular therapy
131i-mibg
Sinai Hospital of Baltimore
 (7.8 away) Contact site
  • 17 views
  • 13 Jan, 2021
  • +83 other locations
Anxiety Intervention for Preschool Children With ASD

This study evaluates the feasibility, acceptability, and preliminary efficacy of a treatment program for anxiety in preschool children with autism spectrum disorder.

pervasive developmental disorder
autism
anxiety
Kennedy Krieger Institute
 (10.0 away) Contact site
  • 47 views
  • 13 Jan, 2021
  • 1 location
Behavioral Weight Loss Program for Cancer Survivors in Maryland

Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project

tamoxifen
breast cancer
cancer
Johns Hopkins ProHealth
 (7.7 away) Contact site
  • 0 views
  • 04 Oct, 2020
  • 1 location